## UBER: Uber Technologies, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -6.2% below STRENGTH zone (4.0-10.0%); PEG 5.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 3, Bearish: 6)

**1. 'Taken for a Ride': Ohio joins multistate Uber lawsuit**
- Source: WFMJ.com | 20251216T234601 | Bearish | Relevance: 100%
- Ohio has joined a multistate lawsuit against Uber USA, LLC and Uber Technologies, Inc. for alleged deceptive practices related to its Uber One subscription service. The lawsuit claims Uber misled customers with free trials that automatically converted to paid subscriptions, exaggerated savings, and made cancellation difficult. It seeks refunds, civil penalties, and a court order to prevent future deceptive practices.

**2. Maryland Sues Uber Over Alleged Subscription Traps That Hit Riders’ Wallets**
- Source: Daily Voice | 20251216T220857 | Bearish | Relevance: 100%
- Uber is being sued by Maryland and a coalition of 21 other states, including Virginia, over allegations of deceptive subscription practices. The lawsuit claims Uber lures consumers into paid "Uber One" subscriptions with misleading free trials and overpromised savings, charges them without clear consent, and makes it extremely difficult to cancel. Officials are seeking restitution for consumers, civil penalties, and an injunction to halt these practices.

**3. Uber Stock (UBER) Slides on FTC Uber One Lawsuit as Analysts Hold Bullish Targets — What to Know on Dec. 16, 2025**
- Source: ts2.tech | 20251216T120345 | Somewhat-Bearish | Relevance: 100%
- Uber (NYSE: UBER) stock traded lower on December 16, 2025, due to an escalated FTC lawsuit concerning its Uber One subscription program, which regulatory bodies allege involved unauthorized charges and difficult cancellations. Despite this, Wall Street analysts maintain a "Buy" consensus with an average price target of $112.06, factoring in Uber's expanding profitability, share repurchases, and growing autonomous vehicle partnerships. The company's Q3 2025 results showed strong growth, and its push into autonomous platforms and broader logistics services, despite regulatory challenges, continues to fuel long-term optimism.

**4. AG Yost Joins Multistate Lawsuit Against Uber Over Alleged Deceptive Subscription Practices**
- Source: Scioto Post | 20251216T100841 | Bearish | Relevance: 100%
- Ohio Attorney General Dave Yost has joined a multistate lawsuit against Uber USA, LLC and Uber Technologies, Inc., accusing the company of deceptive practices related to its Uber One subscription service. The lawsuit, originally filed by the Federal Trade Commission, alleges Uber misled consumers with "free trials" that automatically converted to paid subscriptions without clear notice, exaggerated savings, made cancellations difficult, and sometimes charged customers prematurely. The legal action seeks refunds, civil penalties, and an injunction against these practices.

**5. RBC Capital Reaffirms a Buy Rating on Uber Technologies (UBER)**
- Source: Finviz | 20251216T040835 | Bullish | Relevance: 100%
- RBC Capital analyst Brad Erickson reaffirmed a Buy rating on Uber Technologies (NYSE: UBER) with a $110 price target. This comes as Uber launched Robotaxi passenger rides in Dubai in partnership with the Roads and Transport Authority (RTA) and WeRide. The trial service currently includes an on-board specialist, with plans for a completely driverless commercial service in early 2026.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $110 | $115 | -4% |
| 2025-12-03 | Arete Research | $125 | $82 | +52% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-03 | Arete Research | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.00M) |
| Sells | 19 ($2.67M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.7%)
- Blackrock Inc.: 7.3% (-0.4%)
- Capital Research Glo: 5.3% (-8.1%)
- State Street Corpora: 4.3% (+0.0%)
- Morgan Stanley: 3.8% (+4.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 5.0x requires aggressive growth execution.
3. Long-term trend broken: trading 9.0% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 5.02 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 73%, margin 34%). Balance sheet: $2.2B free cash flow. Insider selling cluster ($2.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $166.2B |
| Beta | 1.19 |
| 52W Range | $59.75 - $101.99 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.02 |
| Forward P/E | 22.2 |
| Current P/E | 14.8 |
| YoY Growth | -33.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -3.4% to -6.2% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 10.2pp (needs >4.0% for momentum thesis). AM_20 at -6.9% indicates price below own 20MA trend. Underperforming sector by 5.8pp, stock-specific weakness. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram bearish (-0.76), momentum weakening. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -6.25% (CS: 8) | Weak |
| RSI_14 | 32.4 | Neutral |
| MACD Histogram | -0.76 | Bearish |
| vs SMA20 | 0.931x | Below |
| vs SMA50 | 0.880x | Below |
| vs SMA200 | 0.910x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $79.70
- **Stop Loss:** $74.18 (6.9% risk)
- **Target:** $85.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 172
- **Position Value:** $13,708.40
- **Portfolio %:** 13.71%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-04 (Est: $0.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.69 | $3.11 | +353.2% |
| 2025Q2 | $0.62 | $0.63 | +1.1% |
| 2025Q1 | $0.50 | $0.83 | +65.0% |
| 2024Q4 | $0.48 | $3.21 | +573.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*